In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Controversies in cardiovascular risk assessment and prevention
Session

Event : ESC Congress 2018

Topic : Risk Factors and Prevention – Cardiovascular Risk Assessment

  • Session type : Moderated Posters
  • Date : 28 August 2018
  • Time : 12:05 - 12:55

7 presentations in this session

Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy

Event : ESC Congress 2018

  • Session : Controversies in cardiovascular risk assessment and prevention
  • Speaker : B Mihaylova (Oxford,GB)

Added predictive value of follow-up blood-pressure measurements after alteration of therapy on cardiovascular risk in patients with hypertension

Event : ESC Congress 2018

  • Session : Controversies in cardiovascular risk assessment and prevention
  • Speaker : NEM Jaspers (Utrecht,NL)

Optimizing outreach strategy to identify individuals at risk for diabetes and/or cardiovascular disease: a study of the Sodertalje municipality in Sweden

Event : ESC Congress 2018

  • Session : Controversies in cardiovascular risk assessment and prevention
  • Speaker : B Shahim (New York,US)

Sex hormone-binding globulin, aging, and cardiovascular risk

Event : ESC Congress 2018

  • Session : Controversies in cardiovascular risk assessment and prevention
  • Speaker : E Aribas (Oisterwijk,NL)

Significant reduction of Framingham risk score in hypogonadal men receiving long-term testosterone therapy: real-life evidence from a 10-year registry

Event : ESC Congress 2018

  • Session : Controversies in cardiovascular risk assessment and prevention
  • Speaker : F Saad (Berlin,DE)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are